These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 25865200)
1. Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections. Mancini N; Marrone L; Clementi N; Sautto GA; Clementi M; Burioni R Future Microbiol; 2015; 10(4):665-82. PubMed ID: 25865200 [TBL] [Abstract][Full Text] [Related]
2. Ready-to-use T cells for infection after stem-cell transplant. Gilbert JA Lancet Oncol; 2017 Sep; 18(9):e519. PubMed ID: 28826590 [No Abstract] [Full Text] [Related]
3. Diagnosis and treatment of opportunistic infections in immunocompromised surgical patients. Dunn DL Am Surg; 2000 Feb; 66(2):117-25. PubMed ID: 10695740 [TBL] [Abstract][Full Text] [Related]
4. [Complications of hematopoietic stem cell transplantation and the treatment: infections]. Ishida Y; Sugawara T Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1344-50. PubMed ID: 16097590 [No Abstract] [Full Text] [Related]
5. Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections. Pikman R; Ben-Ami R Immunotherapy; 2012 Dec; 4(12):1869-82. PubMed ID: 23240754 [TBL] [Abstract][Full Text] [Related]
6. Bacterial, viral, fungal, and parasitic infections in HIV disease and AIDS. Berger TG; Greene I Dermatol Clin; 1991 Jul; 9(3):465-92. PubMed ID: 1873926 [TBL] [Abstract][Full Text] [Related]
7. Adoptive T-cell transfer for refractory viral infections with cytomegalovirus, Epstein-Barr virus or adenovirus after allogeneic stem cell transplantation. Feucht J; Joachim L; Lang P; Feuchtinger T Klin Padiatr; 2013 May; 225(3):164-9. PubMed ID: 23700092 [TBL] [Abstract][Full Text] [Related]
8. Treatment of fungal and other opportunistic infections in immunocompromised patients. Wade JC Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282 [TBL] [Abstract][Full Text] [Related]
9. The role of immunoreconstitution in the management of refractory opportunistic fungal infections. Roilides E; Dignani MC; Anaissie EJ; Rex JH Med Mycol; 1998; 36 Suppl 1():12-25. PubMed ID: 9988488 [TBL] [Abstract][Full Text] [Related]
11. Host immune reactivity and antifungal chemotherapy: the power of being together. Romani L J Chemother; 2001 Aug; 13(4):347-53. PubMed ID: 11589476 [TBL] [Abstract][Full Text] [Related]
12. Prospects for adoptive T-cell therapy for invasive fungal disease. Castellano-Gonzalez G; Clancy LE; Gottlieb D Curr Opin Infect Dis; 2017 Dec; 30(6):518-527. PubMed ID: 28984641 [TBL] [Abstract][Full Text] [Related]
13. [Mycoviruses and importance in mycology]. Keçeli SA Mikrobiyol Bul; 2017 Oct; 51(4):404-412. PubMed ID: 29153071 [TBL] [Abstract][Full Text] [Related]
14. Adoptive cell therapies for posttransplant infections. Sutrave G; Gottlieb DJ Curr Opin Oncol; 2019 Nov; 31(6):574-590. PubMed ID: 31593976 [TBL] [Abstract][Full Text] [Related]
15. Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections. Hamad M Scand J Immunol; 2008 Jun; 67(6):533-43. PubMed ID: 18397201 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation. Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867 [TBL] [Abstract][Full Text] [Related]
17. Infectious disease trends among immunocompromised hosts. Young B; Tambyah PA Singapore Med J; 2012 Apr; 53(4):223-9; quiz 230. PubMed ID: 22511041 [TBL] [Abstract][Full Text] [Related]
18. Aspergillus and other fungi. Robinson LA Chest Surg Clin N Am; 1999 Feb; 9(1):193-225, x. PubMed ID: 10079987 [TBL] [Abstract][Full Text] [Related]